Learning objectives

After watching this webinar, participants will understand how: 

• to diagnose HCM patients; and
• patients should be monitored under mavacamten

Needs assessment and expected educational outcome 

To understand how to use mavacamten, a new drug for treatment of HCM that requires advanced echocardiography for diagnosis and monitoring of treatment.

Main topic

• IMAGING

Related topics

• Echocardiography
• Hypertrophic Cardiomyopathy

This webinar is designed for cardiologists working in the field of cardiovascular imaging, and those wishing to update their scientific knowledge on the topic. During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).